Stockscreener 앱 받기
1.4301
4.39%
0.0601
Mindwalk Holdings Corp 주식(HYFT)의 최신 뉴스
MindWalk Uses HYFT AI Platform to Expose Hidden Portfolio and IP Risks in Drug Discovery - TipRanks
MindWalk Applies HYFT® Technology to Detect Functional Adjacency Linked to Portfolio Risk in AI-Designed Therapeutics - Yahoo Finance
MindWalk Launches HYFT Technology to Address Drug Development Risks - intellectia.ai
After Leaping 47% MindWalk Holdings Corp. (NASDAQ:HYFT) Shares Are Not Flying Under The Radar - 富途牛牛
MindWalk Validates Platform Precision with Breakthrough Discovery Targeting Pathogenic TDP-43 in Neurodegenerative Disease - BioSpace
Mindwalk Validates Platform Precision with Breakthrough Discovery Targeting Pathogenic Tdp-43 in Neurodegenerative Disease - marketscreener.com
Scientists trace a hidden flu constraint across strains and hosts - Stock Titan
REPEAT/MindWalk Advances Universal Influenza Program with a Breakthrough Functional Insight - Yahoo Finance
MindWalk (HYFT) Makes Progress in Influenza Research with Key Di - GuruFocus
MindWalk Holdings Corp. Advances Universal Influenza Program with A Breakthrough Functional Insight - marketscreener.com
MindWalk Advances Universal Influenza Program with a Breakthrough Functional Insight - 01net
MindWalk Unveils Cross-Strain Functional Constraint to Advance Universal Flu Vaccine Effort - TipRanks
MindWalk : Charter of the Audit Committee of the Board of Directors - marketscreener.com
MindWalk Holdings Corp.'s (NASDAQ:HYFT) P/S Is Still On The Mark Following 38% Share Price Bounce - Sahm
MindWalk Holdings Corp. (HYFT) Competitors - Meyka
12 Health Care Stocks Moving In Monday's After-Market Session - Sahm
HYFT: MindWalk Holdings Corp.Balance Sheet - Zacks Investment Research
MindWalk Holdings Corp. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:HYFT) 2025-12-18 - Seeking Alpha
MindWalk Holdings Corp. (HYFT) reports Q2 loss, lags revenue estimates - MSN
MindWalk : Second Quarter 2026 Transcript - marketscreener.com
MindWalk reports 54% revenue growth in Q2 fiscal 2026 By Investing.com - Investing.com Australia
MindWalk Holdings Corp.Common Stock (NQ: HYFT - Markets Financial Content
MindWalk Holdings Corp. (HYFT) Reports Q2 Loss, Lags Revenue Estimates - sharewise.com
MindWalk Holdings Corp (HYFT) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and ... By GuruFocus - Investing.com Canada
MindWalk Holdings Corp (HYFT) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic Innovations - GuruFocus
MindWalk Holdings Corp (HYFT) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and ... - Yahoo Finance
HYFT Stock Price and Chart — NASDAQ:HYFT - TradingView — Track All Markets
Earnings call transcript: MindWalk’s Q2 2025 sees 54% revenue growth By Investing.com - Investing.com South Africa
Earnings call transcript: MindWalk’s Q2 2025 sees 54% revenue growth - Investing.com
MindWalk Holdings Corp. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2025 - marketscreener.com
MindWalk Reports Record Growth and Announces Strategic Progress on Its AI Asset Pipeline - Business Wire
MindWalk reports 54% revenue growth in Q2 fiscal 2026 - Investing.com India
MindWalk Holdings (HYFT) Reports Strong Revenue Growth Despite E - GuruFocus
MindWalk Holdings Emphasizes AI-Driven Strategy in Latest Financial Release - TipRanks
MindWalk Holdings Corp. (HYFT) provides Q2 MD&A and financials update - Stock Titan
[6-K] MindWalk Holdings Corp. Current Report (Foreign Issuer) | HYFT SEC FilingForm 6-K - Stock Titan
Stock Market Today: Dow Futures, S&P 500 Advance Ahead Of Key Economic Data: iRobot, Argenx, MindWalk In Focus - Benzinga
Why MindWalk Holdings Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket - Sahm
Argenx, Navan And 3 Stocks To Watch Heading Into Monday - Benzinga
Here are the major earnings before the open Monday - MSN
mindwalk holdings corp. Earnings dates - RTTNews
Pre-Market Earnings Report for December 15, 2025 : HYFT - Nasdaq
Earnings Outlook For ImmunoPrecise Antibodies - Benzinga
0.22%
1.70%
자본화:
|
볼륨(24시간):